Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
2018 · The Lancet Neurology · 177 citations
https://doi.org/10.1016/s1474-4422(18)30319-3
R
Roberta Ortiz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
965
Citations
15
h-index
18
i10-index
Roberta Ortiz is an academic researcher from Autonomous University of Chihuahua. The author has contributed to research in topics: Childhood Cancer Survivors' Quality of Life & Acute Lymphoblastic Leukemia research & Renal and related cancers. The author has an h-index of 15, co-authored 34 publications.
ORCID: 0000-0002-8287-0928Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat